Skip to main content
OpenTrials
Completed

NCT Number: NCT05678816

Effect Of Breather On Pulmonary And Physical Function In Post Stroke Survivors

Stroke is the second major cause of death and disability worldwide with over 13 million new cases annually.

Egypt, a low-middle-income country, is the most populated nation in the Middle East with a high overall crude prevalence rate of stroke (963/100,000 inhabitants), accounting for 6.4% of all deaths and the incidence of stroke annually is approximately 150,000-210,000.

Stroke has a direct impact on health systems, resulting in high costs, and is also considered a global public health problem due to serious disabilities, functional limitations and compromised quality of life (QoL).

The Breather a drug-free, evidence-based inspiratory/expiratory respiratory muscle training (RMT) device used by Dysphagia, COPD, CHF, Parkinson's, and neuromuscular disease patients, as well as children 4+ and adults interested in healthy aging.

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Cairo University, Giza, Egypt

Loading trial locations.

About this study

Stroke is a leading cause of death and disability in globally and particularly in low and middle-income countries, and this burden is increasing.

The expected spontaneous biological recovery follows the "proportional recovery rule" - most patients recover 70% of their impaired motor or verbal function during the first three months after stroke however, 90% of them have residual deficit.

Stroke patients may experience a reduction of up to 50% in respiratory function when compared to age- and gender-matched norms. The reduction in respiratory function can lead to decreased endurance, dyspnea and increased sedentary behaviour, as well as an elevated risk of recurrent stroke. The reduction in respiratory function may also cause aspiration, leading to pneumonia. Previous research showed that pneumonia was an independent risk factor for mortality and a poor prognosis in stroke patients. Research also showed that a reduction in respiratory muscle and abdominal muscle strength contributed to pulmonary and respiratory dysfunction following a stroke.

After a stroke, the respiratory center and related motor pathways can directly decrease respiratory muscle strength and subsequently induce a change in breathing patterns. As a result, pneumonia, pulmonary ventilation disorders, lung injury, lung ischemia reperfusion injury, decreased pulmonary compliance, abnormal posture, and obstructive sleep apnea can occur following a stroke. Thus, pulmonary rehabilitation is critical to reducing these complications. The main forms of pulmonary rehabilitation include exercise training, respiratory muscle training, oxygen therapy, noninvasive ventilation, nutrition support, social psychological support, and health education.

The inspiratory muscles can be specifically trained, with improvement of both muscle strength and endurance by using the breather device.

As result utilizing the breather may help stroke patients recover quickly and avoid respiratory complication.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Sixty patients were selected from both sexes.Their age were from 50 to 65 years old
  • All patients were medically stable.
  • All patients had the ability to understand and follow simple verbal instructions.
  • All patients were in subacute stage from about 3 to 6 months post lesion.

Exclusion criteria

  • Patients with severe acute illness.
  • Chronic unstable pulmonary and/or cardiac disease.
  • Impaired level of consciousness and evidence of gross cognitive problems.
  • Patients undergoes chemotherapy.
  • Active hemoptysis, untreated pneumothorax, recent esophageal surgery.
  • Recent oral, facial or skull trauma / surgery, acute sinusitis, epistaxis.
  • Smokers.
  • Any oral dysfunction that interfere with using the breather.
  • Un controlled BP systole more than180 or diastole more than 90.

Treatment and study plan

BREATHER

Device

respiratory muscle trainer used to strength inspiratory an expiratory muscles through breathing in and out against aresistence which is determined individually according to each patient.

physiotherapy prgramme for rehabilitation of stroke patients

Other

physiotherapy prgramme for rehabilitation of stroke patients which include:

  • Passive stretching exercise, strengthening exercise.
  • Postural control and balance exercise from different positions as quadruped, kneeling, sitting and standing.
  • Gait training.

Primary outcomes

  1. forced expiratory volium in first second FEV1 in litres

    Time frame: 6 weeks

    fifty patients will be assessed for their FEV1 using spirometer

  2. foced vital capacity FVC in litres

    Time frame: 6 weeks

    fifty patients will be assessed for their FVC using spirometer

  3. peak inspiratory flow PIF in litres per second

    Time frame: 6 weeks

    fifty patients will be assessed for their PIF using spirometer

  4. peak expiratory flow PEF in litres per second

    Time frame: 6 weeks

    fifty patients will be assessed for their PEF using spirometer

Secondary outcomes

  1. Chest expansion in centimeters using tape measurement

    Time frame: 6 weeks

    sixty patient willl be assessed for thier chest expansion tape measurement will be used to assess difference in circumference of chest between full expiration and full inspiration.

  2. oxygen saturation in percentage using spirometer

    Time frame: 6 weeks

    spirometer will be used to indirectly measure saturation of blood by oxygen.

  3. six minute walk distance in metersused to assess functional capacity of patients

    Time frame: 6 weeks

    the distance walked within six minute will be calculated for every patient

  4. stroke impact scale to assess the effect of stroke on different domains astanderdized score ranging from 0 to 100 is calculated for all domains with higher score indicating a higher quality of life

    Time frame: 6 weeks

    The stroke impact scale was developed from the perspectives of both patients and care givers. The current stroke impact scale 3.0 is a revised version of the original SIS , with established reliability and validity. The SIS 3.0 contains 59 items measuring eight domains, including strength, hand function, activity of daily living, mobility, communication, emotion, memory/thinking, and participation, with a single item assessing perceived overall recovery from stroke

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Jan 10, 2023
Registry last updated
Jan 10, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.